Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Biocept Inc (NQ: BIOC )

4.410 USD +0.130 (+3.04%)
Official Closing Price Updated: 7:59 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biocept Inc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers DiaMedica Therapeutics (NASDAQ:DMAC) shares increased by 6.17% to $9.98 during Thursday's after-market session. DiaMedica ... 
Tags KURA BIOC ECOR
From Benzinga
Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System
Biocept, Inc. (Nasdaq: BIOC) will host a webinar featuring leading neuro-oncologists to discuss the use of the Company’s proprietary cerebrospinal fluid (CSF) assay for diagnosing and managing tumors... 
From Business Wire News Releases
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040... 
From Business Wire News Releases
Proactive news headlines including Milestone Scientific, Nextleaf Solutions, Nano One Materials and Delta 9 Cannabis Inc
Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: 
From GlobeNewswire News Releases
Biocept to Host Key Opinion Leader Webinar on April 8 to Discuss its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will host a webinar featuring leading neuro-oncologists to discuss the use of the Company’s... 
From Business Wire News Releases
41 Stocks Moving In Tuesday's Mid-Day Session
Gainers VirTra, Inc. (NASDAQ: VTSI) shares jumped 53.6% to $7.34 after the company reported better-than-expected Q4 ... 
Tags MEDS ORPH Benzinga
From Benzinga
Thinking about buying stock in Biocept, AbCellera Biologics, Novan, Seelos Therapeutics, or SRAX?
InvestorsObserver issues critical PriceWatch Alerts for BIOC, ABCL, NOVN, SEEL, and SRAX. 
From PR Newswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Monopar Therapeutics (NASDAQ:MNPR) stock rose 20.83% to $6.96 during Tuesday's pre-market session. The ... 
Tags BIOC XBIO ORGO
From Benzinga
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ONCR ADAG PIRS
From Benzinga
33 Stocks Moving in Tuesday's Pre-Market Session
Gainers VirTra, Inc. (NASDAQ: VTSI) rose 125.5% to $10.78 in pre-market trading after the company reported better-than-expected Q4 ... 
Tags MOVE ACY WAFU
From Benzinga
A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, House Price Data
Pre-open movers U.S. stock futures traded mixed in early pre-market trade as the Wall Street closed mixed in the previous session ... 
Tags A Peek Into The Markets MKC News
From Benzinga
5 Stocks To Watch For March 30, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects McCormick & Company, Incorporated (NYSE: MKC) ... 
Tags Earnings Market News Pre/Market Outlook
From Benzinga
8 Stocks Moving In Monday's After-Hours Session
Gainers SRAX (NASDAQ: SRAX) shares are trading higher after the company reported Q4 earnings results, issued Q2 sales guidance and ... 
Tags News BIOC MEDS
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Biocept (NASDAQ:BIOC) stock moved upwards by 36.69% to $7.04 during Monday's after-market session. At the close, ... 
Tags BIOC SCPH General
From Benzinga
Biocept: Q4 Earnings Insights
Shares of Biocept (NASDAQ:BIOC) moved higherin after-market trading after the company reported Q4 results. Quarterly ... 
Tags Market News Earnings Benzinga
From Benzinga
Biocept Reports 2020 Fourth Quarter and Full Year Financial Results
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and 12 months ended December 31, 2020 and provides a... 
From Business Wire News Releases
Earnings Scheduled For March 29, 2021
Companies Reporting Before The Bell • Acacia Research (NASDAQ:ACTG) is likely to report earnings for its fourth ... 
Tags News BIOC GOED
From Benzinga
The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness. The ... 
Tags Benzinga DARE AZRX
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers 180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 48.04% to $8.69 during Friday's pre-market session. ... 
Tags OTLK ATNF Top Gainers
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 39.95% to $6.34 during Wednesday's pre-market session. The ... 
Tags IRIX Markets BCLI
From Benzinga
Biocept to Report 2020 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 29, 2021
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it will release financial results for the three and 12 months ended December 31,... 
From Business Wire News Releases
3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy
Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc(NASDAQ:GNMK) in a $1.8 billion dealon Monday, the same ... 
Tags Biotech Penny Stocks VCYT
From Benzinga
Biocept to Participate in Three Virtual Investment Conferences in March
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that President and CEO Michael Nall will participate in three upcoming virtual... 
From Business Wire News Releases
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 38,250... 
From Business Wire News Releases
Proactive news headlines including Energy Fuels, Tartisan Nickel Corp, Medexus Pharmaceuticals and Falcon Gold
Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: 
From GlobeNewswire News Releases
Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load
COVID-19 test, based on Aegea's next-generation COVID-19 assay kit using Switch-Blocker[™] technology, may provide answers that support screening and managing patients 
From PR Newswire
Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load
Aegea Biotechnologies & Biocept enter supply agreement to validate and commercialize new COVID-19 test to help screen, manage, and evaluate patients. 
From Business Wire News Releases
Biocept Inks Research Pact With Protean BioDiagnostics For Target Selector Kit Advantages In Lung Cancer
Biocept Inc(NASDAQ:BIOC)will collaborate withProtean BioDiagnostics Incto research Biocept's Target ... 
Tags Market News lung cancer Benzinga
From Benzinga
Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector™ Assay Kit for Non-Small Cell Lung Cancer Patients
Biocept and Protean BioDiagnostics Collaborate to Demonstrate Advantages of Biocept’s Target Selector Assay for Non-Small Cell Lung Cancer Patients. 
From Business Wire News Releases
Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will present data showing that its Target Selector™ molecular assay kit detects mutations in up... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.